These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31200326)

  • 1. Overview of "home" cultivation policies and the case for community-based cannabis supply.
    Belackova V; Roubalova Stefunkova M; van de Ven K
    Int J Drug Policy; 2019 Sep; 71():36-46. PubMed ID: 31200326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Should I Buy or Should I Grow?" How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic.
    Belackova V; Maalsté N; Zabransky T; Grund JP
    Int J Drug Policy; 2015 Mar; 26(3):296-310. PubMed ID: 25655217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding and learning from the diversification of cannabis supply laws.
    Kilmer B; Pacula RL
    Addiction; 2017 Jul; 112(7):1128-1135. PubMed ID: 27891693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing relationship?
    Borodovsky JT; Budney AJ
    Int J Drug Policy; 2017 Dec; 50():102-110. PubMed ID: 29102847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulating Cannabis Social Clubs: A comparative analysis of legal and self-regulatory practices in Spain, Belgium and Uruguay.
    Decorte T; Pardal M; Queirolo R; Boidi MF; Sánchez Avilés C; Parés Franquero Ò
    Int J Drug Policy; 2017 May; 43():44-56. PubMed ID: 28189980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the harms of cannabis cultivation in Belgium.
    Paoli L; Decorte T; Kersten L
    Int J Drug Policy; 2015 Mar; 26(3):277-89. PubMed ID: 25599596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When prohibition works: Comparing fireworks and cannabis regulations, markets, and harms.
    Caulkins JP; Reimer KV
    Int J Drug Policy; 2023 Aug; 118():104081. PubMed ID: 37315476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six policy lessons relevant to cannabis legalization.
    Shover CL; Humphreys K
    Am J Drug Alcohol Abuse; 2019; 45(6):698-706. PubMed ID: 30870053
    [No Abstract]   [Full Text] [Related]  

  • 9. New Zealand's 'Cannabis Legalisation and Regulation Bill': an evidence-based assessment and critique of essential regulatory components towards policy outcomes.
    Fischer B; Daldegan-Bueno D
    N Z Med J; 2020 Jul; 133(1519):103-111. PubMed ID: 32777801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public health implications of legalising the production and sale of cannabis for medicinal and recreational use.
    Hall W; Stjepanović D; Caulkins J; Lynskey M; Leung J; Campbell G; Degenhardt L
    Lancet; 2019 Oct; 394(10208):1580-1590. PubMed ID: 31657733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home cannabis cultivation in the United States and differences by state-level policy, 2019-2020.
    Wadsworth E; Schauer GL; Hammond D
    Am J Drug Alcohol Abuse; 2022 Nov; 48(6):701-711. PubMed ID: 36288408
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessing the concordance between illicit drug laws on the books and drug law enforcement: Comparison of three states on the continuum from "decriminalised" to "punitive".
    Belackova V; Ritter A; Shanahan M; Hughes CE
    Int J Drug Policy; 2017 Mar; 41():148-157. PubMed ID: 28190670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Into the void: Regulating pesticide use in Colorado's commercial cannabis markets.
    Subritzky T; Pettigrew S; Lenton S
    Int J Drug Policy; 2017 Apr; 42():86-96. PubMed ID: 28173984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Incorporation of Lessons From Tobacco Control in City and County Laws Regulating Legal Marijuana in California.
    Silver LD; Naprawa AZ; Padon AA
    JAMA Netw Open; 2020 Jun; 3(6):e208393. PubMed ID: 32558915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How will cannabis legalization affect health, safety, and social equity outcomes? It largely depends on the 14 Ps.
    Kilmer B
    Am J Drug Alcohol Abuse; 2019; 45(6):664-672. PubMed ID: 31264899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-medical cannabis in North America: an overview of regulatory approaches.
    Lancione S; Wade K; Windle SB; Filion KB; Thombs BD; Eisenberg MJ
    Public Health; 2020 Jan; 178():7-14. PubMed ID: 31600630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in patterns of cannabis use among youth: Prevalence, perceptions of harm and driving under the influence in the USA where non-medical cannabis markets have been established, proposed and prohibited.
    Wadsworth E; Hammond D
    Drug Alcohol Rev; 2018 Nov; 37(7):903-911. PubMed ID: 29992695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis legalisation: should doctors be concerned?
    Kanniah G; Kumar S
    N Z Med J; 2021 Jun; 134(1537):84-90. PubMed ID: 34239164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global patterns of domestic cannabis cultivation: sample characteristics and patterns of growing across eleven countries.
    Potter GR; Barratt MJ; Malm A; Bouchard M; Blok T; Christensen AS; Decorte T; Frank VA; Hakkarainen P; Klein A; Lenton S; Perälä J; Werse B; Wouters M
    Int J Drug Policy; 2015 Mar; 26(3):226-37. PubMed ID: 25582281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Dangerous Drugs Act Amendment in Jamaica: Reviewing goals, implementation, and challenges.
    Davenport S; Pardo B
    Int J Drug Policy; 2016 Nov; 37():60-69. PubMed ID: 27596698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.